Millipore Sigma Vibrant Logo
Attention: We have moved. EMD Millipore products are no longer available for purchase on emdmillipore.com.Learn More

565840 SHIP2 Inhibitor, AS1938909 - Calbiochem

Overview

Replacement Information

Key Specifications Table

Empirical Formula
C₁₉H₁₃Cl₂F₂NO₂S

Products

Catalog NumberPackaging Qty/Pack
565840-10MG Glass bottle 10 mg
Description
OverviewA cell-permeable thiophenecarboxamide compound that is shown to increase glucose metabolism and activate intracellular insulin signaling. Acts as a potent, competitive and reversible inhibitor of SHIP2 activity (Ki = 0.44 µM for hSHIP2) with moderate to excellent selectivity over SHIP1 and other related phosphatases (IC50 = 0.18, 0.57, 21, > 50, > 50 and > 50 µM for mSHIP2, hSHIP2, hSHIP1, hPTEN, h-synaptojanin and h-myotubularin, respectively). Elevates insulin-induced pAkt-Ser473 levels and enhances glucose transporter GLUT1 mRNA expression in L6 myotubes. SHIP1 Inhibitor, 3AC is also available (Cat. No. 565835).
Catalogue Number565840
Brand Family Calbiochem®
Synonyms3-(2,4-Dichlorobenzyl)oxy]-N-(2,6-difluorobenzyl)thiophene-2-carboxamide, SH2 domain-containing inositol 5ʹ-phosphatase 2 (SHIP2) Inhibitor, AS1938909
References
ReferencesSuwa, A., et al. 2010. Eur. J. Pharmacol. 642, 177.
Suwa, A., et al. 2009. Br. J. Pharmacol. 158, 879.
Product Information
FormOff-white solid
Hill FormulaC₁₉H₁₃Cl₂F₂NO₂S
Chemical formulaC₁₉H₁₃Cl₂F₂NO₂S
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Purity≥95% by HPLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
Toxicity Standard Handling
Storage +2°C to +8°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalog Number GTIN
565840-10MG 04055977191936

Documentation

SHIP2 Inhibitor, AS1938909 - Calbiochem SDS

Title

Safety Data Sheet (SDS) 

SHIP2 Inhibitor, AS1938909 - Calbiochem Certificates of Analysis

TitleLot Number
565840

References

Reference overview
Suwa, A., et al. 2010. Eur. J. Pharmacol. 642, 177.
Suwa, A., et al. 2009. Br. J. Pharmacol. 158, 879.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision27-August-2018 JSW
Synonyms3-(2,4-Dichlorobenzyl)oxy]-N-(2,6-difluorobenzyl)thiophene-2-carboxamide, SH2 domain-containing inositol 5ʹ-phosphatase 2 (SHIP2) Inhibitor, AS1938909
DescriptionA cell-permeable thiophenecarboxamide compound that is shown to increase glucose metabolism and activate intracellular insulin signaling. Acts as a potent, competitive and reversible inhibitor of SHIP2 activity (Ki = 0.44 µM for hSHIP2) with moderate to excellent selectivity over SHIP1 and other related phosphatases (IC50 = 0.18, 0.57, 21, > 50, > 50 and > 50 µM for mSHIP2, hSHIP2, hSHIP1, hPTEN, h-synaptojanin and h-myotubularin, respectively). Elevates insulin-induced pAkt-Ser473 levels and enhances glucose transporter GLUT1 mRNA expression in L6 myotubes. SHIP1 Inhibitor, 3AC is also available (Cat. No. 565835).
FormOff-white solid
Intert gas (Yes/No) Packaged under inert gas
Chemical formulaC₁₉H₁₃Cl₂F₂NO₂S
Structure formulaStructure formula
Purity≥95% by HPLC
SolubilityDMSO (50 mg/ml)
Storage Protect from light
+2°C to +8°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Standard Handling
ReferencesSuwa, A., et al. 2010. Eur. J. Pharmacol. 642, 177.
Suwa, A., et al. 2009. Br. J. Pharmacol. 158, 879.